Polypharmacy, the simultaneous use of multiple drugs to treat patients, projects a significant increase in possible adverse interactions among the drugs being co-consumed. Adverse Drug Reactions (ADRs) cause over 106,000 deaths, 74,000 emergency room visits and 19,000 hospitalizations annually in USA alone, making ADRs the 4th leading cause of death in US, ahead of pulmonary disease, diabetes, AIDS, pneumonia and automobile deaths.
Current Pharmacovigilance resources are predominantly provider focused, leaving the decision making in the hands of 3rd parties. These resources are not universally applicable due to geographic fragmentation in drug branding, use of generic drugs and non-liable stakeholders due to differences in insurance structure, enforcement of medical profession liability and medicine dispensing and prescription practices etc.
All these are the drivers for a universally functional, patient driven potential ADR testing/ reporting system. ContraRx offers the most current and technologically advanced patient centric Health drug data and drug decision support engine for patient self-reporting. Our patient driven drug monitoring system is designed to overcome the current challenges and shortcomings. Our intelligent algorithms enable the users from diverse geographic locations to easily and efficiently input queries using regionally prevalent drug and generic brand names.
Additionally, ContraRx integrates auxiliary services impacting safe drug consumption to offer the best in class Pharmacovigilance tools for our users, synchronized with our PharmacoAdherence (like medication non-adherence) and Pharmacogenomics (genetic make-up based variability to drug response) suite of offerings.